Skip to content

Risk factors of renal function recovery in acute kidney injury in critical care patients: a retrospective study based on medical records

Risk factors of renal function recovery in acute kidney injury in critical care patients: a retrospective study based on medical records

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030123
Enrollment
Unknown
Registered
2020-02-23
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute kidney injury

Interventions

Renal function recovery group:N/A
renal function non-recovery group:N/A

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with AKI and sepsis AKI in all ICUs of the study centers were included in the study, and the patients met all the following criteria: 1) Admission to ICU; 2) Aged > 18 years; 3) Meet the criteria for the diagnosis of AKI in the global kidney disease prognostic organization (KIDGO): within 48 hours the SCr rise >= 26.5µmol/L; or within 7 days the SCr rise >= 1.5 times the baseline value; or within 6 hours the urine volume = 2.

Exclusion criteria

Exclusion criteria: Exclusion criteria: Potential subjects who meet the entry criteria will be excluded if they meet any of the following criteria 1) pregnant and perinatal women; 2) In ICU for less than 24 hours; 3) having a history of organ transplantation; 4) Patients with had been renal replacement therapy; 5) Patients and their families cannot cooperate with the researcher.

Design outcomes

Primary

MeasureTime frame
Medical history (hypertension, diabetes, heart disease, liver disease, chronic kidney disease, malignant tumor);Surgery (surgery, bleeding, intraoperative hypotension);Surgical patients (total intraoperative intake/total output, crystal fluid, colloid fluid, blood products);vasoactive drug, nephrotoxic drug;Immediate testing into ICU: PO2/FIO2, lactic acid, HB, TBIL, TNI, BNP, etc.;28-day mortality, 90-day mortality, 1-year mortality, ICU time, hospitalization, cumulative mechanical ventilation;neutrophil gelatinase-associated lipocalin (NGAL), CMTM Family, cytokine-like 1, Lysozyme G-like 1;

Countries

China

Contacts

Public ContactZhu Fengxue

Peking University People's Hospital

fxzhu72@163.com+86 13911005275

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026